Literature DB >> 7405947

Tolerance to dobutamine after a 72 hour continuous infusion.

D A Unverferth, M Blanford, R E Kates, C V Leier.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7405947     DOI: 10.1016/0002-9343(80)90387-3

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  36 in total

1.  Corticosteroid effect on down regulation in beta adrenergic receptors.

Authors:  T Saito; K Yamada; A Kitamura; K Ishihara; H Amamoto; R Ogawa
Journal:  J Anesth       Date:  1992-04       Impact factor: 2.078

2.  Failure of dopexamine to maintain haemodynamic improvement in patients with chronic heart failure.

Authors:  J J Murphy; J R Hampton
Journal:  Br Heart J       Date:  1988-07

Review 3.  Myocardial beta-adrenoceptor function and regulation in heart failure: implications for therapy.

Authors:  D B Barnett
Journal:  Br J Clin Pharmacol       Date:  1989-05       Impact factor: 4.335

Review 4.  The effectiveness of inotropic agents in isolated cardiac preparations from the human heart.

Authors:  E Erdmann
Journal:  Klin Wochenschr       Date:  1988-01-04

5.  Positive inotropic stimulation in the normal and insufficient human myocardium.

Authors:  E Erdmann; M Böhm
Journal:  Basic Res Cardiol       Date:  1989       Impact factor: 17.165

6.  Acute intravenous and sustained oral treatment with the beta1 agonist prenalterol in patients with chronic severe cardiac failure.

Authors:  P J Currie; M J Kelly; K Middlebrook; J Federman; E Sainsbury; J Ashley; A Pitt
Journal:  Br Heart J       Date:  1984-05

Review 7.  Inotropic support of the critically ill patient. A review of the agents.

Authors:  P J Kulka; M Tryba
Journal:  Drugs       Date:  1993-05       Impact factor: 9.546

8.  Intermittent infusion of dobutamine in the therapy of severe congestive heart failure--long-term effects and lack of tolerance.

Authors:  H H Erlemeier; W Kupper; W Bleifeld
Journal:  Cardiovasc Drugs Ther       Date:  1992-08       Impact factor: 3.727

9.  Intravenous levosimendan vs. dobutamine in acute decompensated heart failure patients on beta-blockers.

Authors:  Claes-Håkan Bergh; Bert Andersson; Ulf Dahlström; Kolbjorn Forfang; Matti Kivikko; Toni Sarapohja; Bengt Ullman; Gerhard Wikström
Journal:  Eur J Heart Fail       Date:  2010-04       Impact factor: 15.534

10.  [Early hemodynamic effects of olprinone hydrochloride after coronary artery bypass grafting].

Authors:  A Marui; T Mochizuki; N Mitsui; T Koyama; M Horibe
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  1998-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.